Please login first

The 3rd International Electronic Conference on Biomolecules

23–25 Apr 2024
Event's Timezone: Central European Time
Abstract Submission Deadline
23rd February 2024
Abstract Acceptance Notification
20th March 2024

Registration Deadline
17th April 2024

Biomolecular Structures and Functions, Molecular Mechanisms, Biomolecular Interactions and Networks, Biomaterials, Biocatalysis and Enzyme Engineering, Bioinformatics and Computational Biology
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us Become a Sponsor

IECBM 2024 will be FREE for Participation!

The deadline for abstract submission has extended to 23 February 2024.
Join us today to register and submit your abstract, and be part of cutting-edge discussions and networking opportunities!

Welcome from the Chair

Dear Colleagues,

It is with great enthusiasm that we announce the 3rd International Electronic Conference on Biomolecules (IECBM2024). The conference is organized by the MDPI open-access journal Biomolecules (ISSN: 2218-273X, Impact Factor 5.5), and will be held online from 23 to 25 April 2024.

This conference will provide leading scientists working in the field with an online platform on which to share their latest research and engage in exciting discussions. The main topics and sessions of the conference are:

Biomolecular Structures and Functions;
Molecular Mechanisms in Cellular Processes;
Biomolecular Interactions and Networks;
Biomaterials Design and Characterization;
Biocatalysis and Enzyme Engineering;
Bioinformatics and Computational Biology.

This is an excellent opportunity for biomolecular researchers and scientists to interact with each other, communicate with their colleagues, learn from each other, share ideas and results, help solve problems, and suggest alternative options for a better future. As well as the energetic and dynamic nature of the virtual international conference, another advantage is that you do not need to travel anywhere to attend the conference. You can take advantage of the above opportunities from wherever you live.

Under the virtual conference settings, there are additional advantages: (1) engagement tools that keep energy levels high, (2) participants are given a voice, (3) far stronger attention is received while one is talking, (4) Q&A through “Chat” is also possible if you do not wish to raise your question verbally, (5) polls, (6) feedback through Chat, (7) use of symbols under “Reactions” function to show your voice, appreciation, or a request, (8) greater reach with remote audiences, and (9) the ability to deliver live and pre-recorded presentations simultaneously.
All accepted abstracts will be available online in Open Access form on during and after the conference.

Kind regards,
Prof. Dr. Vladimir N. Uversky, PhD, DSc, FRSB, FRSC
Department of Molecular Medicine, University of South Florida, USA

Follow the conference organizer on Social Media

Event Chair

Department of Molecular Medicine, University of South Florida, USA

Vladimir Uversky is Professor at the College of Molecular Medicine, University of South Florida. He is a biophysicist and obtained his PhD and Doctor of Science (DSc) in Physics and Mathematics at the Moscow Institute of Physics and Technology (1991) and at the Institute Experimental and Theoretical Biophysics, Russian Academy of Sciences (1998), respectively. He spent his early career investigating protein folding at the Institute of Protein Research and the Institute for Biological Instrumentation (Russia). In 1998, he moved to the University of California Santa Cruz to work on protein folding, misfolding, and protein intrinsic disorder. In 2004, he joined the Indiana School of Medicine and, in 2010, the University of South Florida, where he has since been continuing his studies on protein folding, misfolding, and intrinsically disordered proteins. Prof. Vladimir Uversky has authored over 980 scientific publications, edited numerous books, and is also serves as the editor of several scientific journals. He was included in Thomson Reuters list of Highly Cited Researchers in 2014-2020.

Session Chairs

Dr. Alessandro Paiardini

Department of Biochemical Sciences “A. Rossi Fanelli”, Sapienza University of Rome, Italy

Prof. Dr. Jürg Bähler

Department of Genetics, Evolution & Environment and Institute of Healthy Ageing, University College London, UK

Prof. Dr. Piero Crespo

CSIC Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Spain

Dr. Martin Muschol

Department of Physics, University of South Florida, USA

Dr. Tzanko I. Doukov

Macromolecular Crystallographic Group, Stanford Synchrotron Radiation Lightsource, National Accelerator Laboratory, Stanford University, Stanford, USA

Dr. Thomas R. Caulfield

Department of Neuroscience, Department of Cancer Biology, Department of Computational Biology, Department of Neurosurgery, Department of Clinical Genomics, Department of Biochemistry & Molecular Biology , Mayo Clinic, USA

Event Committee Members

David Geffen School of Medicine at UCLA, USA

Gal Bitan got his PhD in organic chemistry from the Hebrew University of Jerusalem, Israel. During his postdoc at Brigham and Women's Hospital/Harvard Medical School, Boston, MA, Dr. Bitan worked on pathologic self-assembly of amyloid ß-protein (Aß) and made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer's disease, including the discovery of one of the earliest oligomers in the assembly cascade, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently a Professor of Neurology. His research program combines basic and translational research focused on neurodegenerative proteinopathies, including Alzheimer's disease, other tauopathies, Parkinson's disease, and atypical parkinsonian disorders.

Data Science Institute, University of Virginia, USA

Philip E. Bourne, PhD, FACMI is the Stephenson Chair and Dean of the School of Data Science and a Professor in the Department of Biomedical Engineering at the University of Virginia. His current research focuses on systems pharmacology (notably neglected tropical diseases and protein kinase targets), structural bioinformatics, scholarly communication, professional development and the development and application of data science methods.

Department of Cardiovascular Diseases, Mayo Clinic, USA

Dr. Zahid is a clinician scientist/cardiologist at Mayo Clinic, Rochester, MN. Her area of expertise is cell penetrating peptide and her work revolves around tissue-specific cell penetrating peptides, cardiac- and lung-targeting families that she is developing as imaging agents and novel vectors for cell-specific delivery.
Research Keywords
cardiac-targeting peptide; protein transduction domains; cilia biology; ciliogenesis; genetics; congenital heart disease; lung targeting peptides; cell penetrating peptides

Department of Chemistry, National and Kapodistrian University of Athens, Greece

Department of Neurosciences, University of Padova, Italy

Instituto de Neurociencias, Miguel Hernández University, Spain

María S. García Gutiérrez is Associate Professor of Pharmacology in the Department of Pharmacology at the Miguel Hernández University (UMH) and researcher at the Institute of Neurosciences, a joint center of the Spanish National Research Council (CSIC) and UMH. She specialized in translational research in neuropsychiatry and addictions, using animal models and processing samples from patients with these pathologies, with the aim of determining the mechanisms underlying them, identifying new targets and treatments, and possible biomarkers for prevention, diagnosis and prognosis. All the results of her research have been published in internationally prestigious peer-reviewed indexed journals (66 publications, first decile or quartile of their category). She has an H-index of 29 (Scopus).

Blizard Institute, Queen Mary University of London, UK

Dr Ping Yip is a Non-Clinical Senior Lecturer in Neuroscience at Queen Mary University of London. He completed his PhD on epilepsy under the supervision of Prof. Brian Meldrum and Dr Marcus Rattray at the Institute of Psychiatry which is now a school of King's College London. He spent much of his post-doctoral time at King's College London working under Prof. Stephen McMahon before he went to work with Prof. Adina Michael-Titus and Prof. John Priestley at Queen Mary University of London. His research focuses on neuroregeneration, neuroplasticity, neuroprotection, and neurodegeneration in several models of spinal cord and peripheral nerve injury in rats and mice. However, he has recently become interested in injury to the brain, in particular newborns with brain injury (Prof. Divyen Shah), adults with traumatic brain injury (Prof. Chris Uff), and motor neurone disease (Prof. Andrea Malaspina). The aim is to detect and understand brain injury from brain tissues and/or biofluids.
Research Keywords
spinal cord injury; traumatic brain injury; hypoxic-ischemic encephalopathy; peripheral nerve injury; amyotrophic lateral sclerosis; neuroinflammation; neuroregeneration; neuroplasticity; neuroprotection; biomarkers; omega-3 fatty acids; microRNA

Department of Women's and Children's Health—SDB, University of Padova, Italy

Research Keywords
protein purification; protein tyr-phosphorylation and dephosphorylation; inflammatory and metabolic dìseases; oxidative stress; eryptosis

Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Norway

Research Keywords
DNA repair; DNA damage response; genetics; primary immunodeficiency; B lymphocyte development; mouse models

Psychology Department, University of Florida, USA

Research Keywords
drug addiction; neuro-psychopharmacology; animal model; molecular mechanism

Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, USA

Research Keywords
cytokine signaling; unfolded protein response; transcriptional control; T helper cell; immunity and inflammation

Department of Clinical Oncology, Queen Elizabeth Hospital, China

Research Keywords
cancer biomarker; evidence-based medicine; extracellular vesicles; genomics; microRNA; molecular diagnostics; non-coding RNAs; nasopharyngeal carcinoma; next-generation sequencing; non-small cell lung cancer; proteomics; drug repurposing and bioinformatic

Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council (CNR), Italy,
Center for Advanced Technology, Adam Mickiewicz University, Uniwersytetu Poznanskiego, Poland

Research Keywords
free radical chemistry; biomimetic chemistry; organic synthesis; reaction mechanism; analytical protocols for biomarkers of radical stress; oxidative DNA damage; lipid modification; fatty acid-based lipidomics

Medway School of Pharmacy, Universities of Kent and Greenwich, UK

Research Keywords
biochemistry of immune responses; anti-tumour immunity; immunotherapy of cancer; cell stress and hypoxic signalling

Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Greece

Dr. Angeliki Chroni, Research Director, heads the Lipoprotein group of the Institute of Biosciences and Applications of the NCSR “Demokritos” in Athens, Greece, since 2005. She holds a BSc in Chemistry (University of Athens, Greece, 1994) and a PhD in Biochemistry (University of Athens, Greece, 2000). Dr. Chroni worked as a post-doctoral fellow (2000-2005) at Boston University School of Medicine, USA. Dr. Chroni has been working for 20 years on understanding the structure-function relationship of apoA-I as well as of apoE, with emphasis on the elucidation of the perturbations in the functional properties of these apolipoproteins that result to human diseases. Recent activities include a) the elucidation of structural and functional defects as the underlying mechanism of the association of natural point mutations in apoA-I with alterations in HDL-cholesterol levels and cardiovascular risk, b) elucidation of the role of natural occurring apolipoprotein E4 variants and lipid homeostasis in Alzheimer’s disease pathogenetic processes, c) correction of structure of apoA-I and apoE variants displaying folding defects using libraries of small molecules and assays in a microplate set-up and d) the detailed characterization of changes in human HDL composition and functions in various pathogenic conditions in order to identify new biomarkers for cardiovascular risk and diagnosis, prognosis and therapy monitoring of disease.
Research Keywords
apolipoprotein structure and function; apolipoprotein A-I; apolipoprotein E; cholesterol; lipoprotein metabolism; dyslipidemia; atherosclerosis; Alzheimer's disease; inflammation

Institute of Biostructures and Bioimaging, CNR, Italy

Research Keywords
protein structure–function; molecular dynamics; computational biology; structural biology; molecular basis of diseases; biophysics

School of Medicine, Cardiff University, UK

After a PhD in Molecular Biology at Cardiff University, Dr Martin began a Post-doctoral career at the then University of Wales College of Medicine (now Cardiff University), investigating the role of Hepatocyte Growth Factor (HGF) on endothelia. This led to the opportunity to examine HGF and its antagonist NK4 in cancer. She has since been involved in researching the role of Tight Junctions in cancer (during metastasis) and in endothelia (during angiogenesis). Her research interests include investigating how Tight Junctions can be modulated to control cancer cell dissociation and invasion, together with a continued interest in angiogenic factors and their role in metastasis. She is has a special interest in the mechanisms whereby HGF can control tight junction assembly and function in both cancer and endothelia. Her work has also involved the examination of HGF and how this cytokine influences stem cells markers in prostate cancer. Other research interests include the interaction of cancer cells in cell-adhesion and cell-signalling and in how the cell adhesion molecule VE-cadherin is involved in angiogenesis. Dr Martin is currently Senior Lecturer in Cell and Tumour Biology at the Cardiff University School of Medicine and is also the Director of Postgraduate Research.
Research Keywords
cancer metastasis; tight junctions; cell adhesion; molecular targets; blood–brain barrier; angiogenesis; endothelial cells; breast cancer

Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, Russia

Deputy Director for Science of the State Research Center for Applied Microbiology and Biotechnology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Obolensk, Russia). He is a specialist in especially dangerous bacterial infections and obtained his PhD in Microbiology at the State Research Center for Applied Microbiology and Biotechnology. He obtained his Doctor of Science (DSc) in Microbiology at the Russian Research Anti-Plague Institute “Microbe” (Saratov, Russia). Dr. Anisimov made fundamental contributions to the study of bacterial pathogenesis and microevolution on the model of Yersinia pestis infection in order to improve means and methods of laboratory diagnosis, vaccine prophylaxis and treatment of plague.
Research Keywords
molecular bacteriology; infectious diseases; molecular biology of host-vector-pathogen interactions; microbial pathogenesis; virulence factors; vaccinology; biotechnology

UND Life Sciences, USA,
Department of Medicine, Omega Hospitals, India,
Department of Biotechnology, Indian Institute of Technology, India

Research Keywords
bioactive lipids; essential fatty acids; polyunsaturated fatty acids; prostaglandins; lipoxins; resolvins; protectins and maresins; reactive oxygen species; lipid peroxidation; cancer; rheumatology; inflammation; immune response; immune checkpoint inhibit

School of Life Sciences, Tsinghua University, China

Haiteng Deng is a professor at School of Life Sciences at Tsinghua University in Beijing. He is the director of the MOE Key Laboratory of Bioinformatics and the director of the Proteomics Center at Tsinghua University. He got his Ph.D. at Pennsylvania State University, and did his postdoctoral studies at University of Alberta and the Oak Ridge National Laboratory. He was a faculty member at Albert Einstein College of Medicine, University of Nebraska, and Rockefeller University. His research interests focus on (1) development and applications of proteomics, metabolomics, and chemical biology techniques; (2) understanding of the function and mechanism of redox biology in aging and neurodegeneration disease, and (3) development of novel therapeutic interventions and diagnostic biomarkers for aging associated diseases. Over the last five years, he has published 135 papers in peer reviewed journals.

Centre for Livestock Interactions with Pathogens (CLiP), Department of Animal, Plant and Soil Sciences, AgriBio, Centre for AgriBiosciences, 5 Ring Road, La Trobe University, Australia

Research Keywords
glycobiology; protein structure; protein-glycan and protein-protein interactions; host-pathogen interactions; recombinant protein expression

Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, USA

Research Keywords
collagen self-assembly; collagen structure and properties; extracellular matrix, tissue biomechanics; mechanotransduction; non-invasive characterization of tissues; wound healing

School of Materials & Engineering, University of Shanghai for Science and Technology, China

Dr. Deng-Guang Yu received his B.S. degree from Beijing University of Chemical Technology, China, in 1991. After ten years working in a state-owned company, he went to Huazhong University of Science and Technology to get his PhD degree in 2007, Wuhan, China. He is presently a full professor in School of Materials and Chemistry in University of Shanghai for Science and Technology. His research mainly focus on drug delivery, nanomaterials and electrohydrodynamic atomization techniques, such as electrospinning, electrospraying and 3D printing.
Research Keywords
biomolecules; electrospinning; electrospraying; biomaterials; drug delivery

Keynote Speakers

Department of Biochemistry and Biomedicine, University of Sussex, UK

Research Keywords
Hsp90; heat shock proteins; chaperone; structure; mechanism; regulation; disease; cancer; neurological disease; drug development

Medway School of Pharmacy, Universities of Kent and Greenwich, UK

Research Keywords
biochemistry of immune responses; anti-tumour immunity; immunotherapy of cancer; cell stress and hypoxic signalling


The registration for IECBM 2024 will be free of charge! The registration includes attendance to all conference sessions.

If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.

Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 17th April 2024.

Instructions for Authors

Procedure for Submission
IECBM 2024 will accept abstracts only. The accepted abstracts will be available online on during and after the conference.
Important Deadlines
  1. Deadline for abstract submission: 23 January 2024 23 February 2024.
  2. Announcement of oral and poster abstract results: 23 February 2024 10 March 2024. You will be notified of the acceptance of an oral/poster presentation in a separate email.

Certificates of Participation are available in your logged-in area of, under “My Certificates” after the conference.

Abstract Submission

Abstract submissions should be completed online by registering with and using the "Submit Abstract" function once logged into the system. No physical template is necessary.

1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All accepted abstracts will be published as one dedicated volume in Biology and Life Sciences Forum (ISSN: 2673-9976). If you wish to publish a full-length proceedings paper, please refer to the “Publication Opportunities” Section.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.

Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.

Note: We only accept live presentations.

Oral Presentation and Slides Submission
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
Poster Presentation
  • Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
  • File format: PDF (.pdf).
  • Size in pixel: 1080 width x 1536 height–portrait orientation.
  • Size in cm: 38,1 width x 54,2 height–portrait orientation.
  • Font size: ≥16.Examples of successful submissions can be viewed here at the following links: (1), (2), (3)
    You can use our free template to create your poster. The poster template can be downloaded HERE.
    The Poster Sessions will take place in Zoom break-out rooms. The rooms will be called after your surname. You will automatically be assigned to your break-out room, however, you will be responsible for your own room, i.e. sharing your screen by yourself, handling the comments in the chat if there are any, etc. People will then be able to visit your room and discuss your poster with you. Please make sure you have the Zoom Desktop client or mobile app, version 5.3.0 or higher.
    We will reach out to you closer to the dates of the conference with more information.
Publication Opportunities

    1. Biomolecules Journal Publication
    Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue, published in Biomolecules (ISSN 2218-273X, Impact Factor 5.5), with a 20% discount on the publication fee. Please note that no other discounts are applicable. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.

    2. Proceeding Paper Publication
    You are welcome to submit a proceeding paper (4-8 pages) to MDPI Biology and Life Sciences Forum (ISSN: 2673-9976) after the conference. Publication of the proceedings will be free of charge.

    Authors are asked to disclose that it is a proceeding paper of the IECBM2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.

    Proceedings submission deadline: 10 June 2024

    Manuscripts for the proceedings issue must be formatted as follows:
    Full author names.
    Affiliations (including full postal address) and authors' e-mail addresses.
    Results and Discussion.

    Potential Conflicts of Interest

    It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.


    MDPI, the publisher of the platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.

    Event Awards

    To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.

    The Awards
    Best Oral Presentation Award and Best Poster Award

    Number of Awards Available: 6

    The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
    The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.

    There will be six winners selected for these awards. The winner will receive a certificate and 200 CHF each.

    Sponsors and Partners

    For information regarding sponsorship and exhibition opportunities, please click here.


    Media Partners

    Conference Secretariat

    Mr. Leo Zou
    Mr. Russell Wang

    For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.